首页> 外文期刊>Pediatric emergency care >Pediatric carbamazepine suspension overdose-clinical manifestations and toxicokinetics.
【24h】

Pediatric carbamazepine suspension overdose-clinical manifestations and toxicokinetics.

机译:小儿卡马西平混悬剂过量的临床表现和毒物动力学。

获取原文
获取原文并翻译 | 示例
           

摘要

Two toddlers ingested unknown quantities of their older sibling's carbamazepine suspension and rapidly manifested central nervous depression requiring intubation in 1 patient. Coma was the primary clinical finding throughout their care with no anticholinergic syndrome, seizures, or dysrhythmia. Both patients recovered without sequelae within 24 hours. Initial carbamazepine concentrations were 36.6 and 22.7 mg/L. The elimination rates (zero-order kinetic) were approximately 1.4 and 0.75 mg/L per hour. We provide the first toxicokinetic data for carbamazepine suspension overdose in children. We confirm that the oral absorption of suspension carbamazepine is rapid necessitating prompt referral to a health care facility for this exposure.
机译:两个幼儿摄入了未知数量的较老兄弟姐妹的卡马西平悬浮液,并迅速表现出中枢神经抑制,需要对1名患者进行插管。昏迷是整个治疗过程中的主要临床发现,无抗胆碱能综合症,癫痫发作或心律不齐。两名患者均在24小时内康复,没有后遗症。卡马西平的初始浓度为36.6和22.7 mg / L。消除速率(零级动力学)约为每小时1.4和0.75 mg / L。我们提供了儿童过量服用卡马西平悬浮液的第一个毒物动力学数据。我们确认,卡马西平混悬液的口服吸收迅速,因此必须立即转诊至医疗机构进行这种暴露。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号